Latest Breaking News On - Ligresti sant - Page 1 : comparemela.com

Press release content from Business Wire. The AP news staff was not involved in its creation. CARMAT announces the first commercial implant of its Aeson® artificial heart July 19, 2021 GMT Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, today announces the first implant of its Aeson® bioprosthetic artificial heart in a commercial setting. First commercial implant and first sale in CARMAT’s history This implant of the Aeson® artificial heart was performed by the team headed by heart surgeon Dr. Ciro Maiello at the Azienda Ospedaliera dei Colli hospital in Naples, one of the hospitals with the greatest experience in the field of artificial hearts in Italy.

United statesFrance generalAlain carpentierCristiano amarelliLigresti santPierre bastid lohasDusan oresanskyCaroline carmagnolDepartment of cardiac surgeryDuke university hospitalEuropean commissionAirbus groupCentre chirurgical marie lannelongueHealth careDuke university hospital onCiro maiello